Last reviewed · How we verify
Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization
Approved treatments
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization patent landscape — cliff calendar, originator estates, attackable patents
- Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization treatment landscape brief
- Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization treatment updates RSS
Frequently asked questions about Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization
What drugs treat Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization?
Tracked treatments include Azactam.
What is the treatment for Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization?
Standard treatment for Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization includes Azactam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization patent cliff · Respiratory Cystic Fibrosis with Pseudomonas aeruginosa Colonization CI report
- Treatment: Azactam · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing